when does compound semaglutide start working How Long for to Work? FDA Warns on Certain Forms

Rathmacher JA et al

Patients report a stronger sense of sexual wellness, responsiveness, and confidence not just physical function but the desire for intimacy

There will also be increased focus on the FDA post-market review assessment of chemicals in food, which IFT weighed in on in these public comments

The most commonly reported adverse events (observed in greater than 5% of clinical trial participants) were nausea, diarrhea, vomiting, constipation, abdominal pain, dyspepsia, injection-site reactions, fatigue, hypersensitivity reactions, eructation, hair loss and gastroesophageal reflux disease

Am J Surg 180(1):3336 Drucker DJ (2024) Efficacy and safety of GLP-1 medicines for type 2 diabetes and obesity